the effects of tolazamide ( 300 mg. daily ) , a new oral hypoglycemic sulfonylurea , and tolbutamide on the blood glucose , serum insulin , cholesterol and triglyceride levels were compared in 14 subjects with maturity-onset diabetes of varying severity .
C0038766
sulfonylurea
C0040374
tolbutamide